The 12 closest competitors and alternatives to Space LiinTech among space biotechnology companies — ranked by similarity to what Space LiinTech actually does, not by market-cap band.
Subscribe to see Space LiinTech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Space LiinTech is a space biopharma company headquartered in Daejeon, South Korea, that develops AI-enabled microgravity platforms for pharmaceutical research.
Space LiinTech is a space biotechnology company headquartered in South Korea. Its most recent funding round, Pre-Series A, raised $4M in May 2024. Xcout tracks 5 named people at Space LiinTech, including Jung-uk Shim (Director & CTO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $4M | 16 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Space LiinTech by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
Spark Biopharma is headquartered in Seoul, South Korea, and focuses on discovering and providing small-molecule therapeutics using phenotypic discovery platforms to improve human health.
Biotechnology
LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
Biotech
IntoCell is a South Korean biotechnology company founded in 2015 and headquartered in Daejeon, specializing in drug-conjugate and related pharmaceutical technologies.
Biotechnology
Y-Biologics is a South Korea-based research and development biotechnology company headquartered in Daejeon. The firm focuses on developing novel antibody-based therapeutics using its proprietary platform technologies and pipelines.
Biotech
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Biotechnology
1STBIO is a South Korea-based biotherapeutics company utilizing a proprietary AI-based drug discovery platform and genomic-based target discovery to enhance R&D efficiency. The firm is dedicated to discovering and developing novel therapeutics for areas of significant unmet medical need with a small team of 29 employees.
Biotechnology
U-Factor Life Science Co., Ltd. is a biotech startup pioneering stem cell-derived conditioned medium and supernatant for drug discovery and anti-aging applications.
Biotechnology
Alteogen is a biotechnology company that researches and develops next-generation bio-betters, biosimilars, and proprietary drug delivery platforms, including long-acting technologies, antibody-drug conjugates (ADCs), and subcutaneous injection conversion technologies. The company serves the global pharmaceutical and healthcare industries by developing advanced biologic drugs and platform solutions.
Biotechnology
Starpax Biopharma Inc. is a Canadian biotechnology research and development company incorporated in 2017 to commercialize cancer-treatment technology licensed from Polytechnique Montréal. The company has developed a platform technology utilizing magnetodrones designed to treat solid tumors while aiming to preserve organ function and avoid traditional side effects.
Biotech
LabGenius Ltd is a biotechnology company (also known as LabGenius Therapeutics) that utilizes machine learning and automation to discover and develop novel protein therapeutics. The company collaborates with major pharmaceutical partners, such as LG Chem, to advance research and development activities.
Biotechnology
Pharos iBio Co., Ltd. is a South Korean biotechnology company that uses artificial intelligence and big-data approaches for drug discovery and development. Its pipeline includes oncology candidates such as PHI-101, a FLT3 inhibitor being developed for acute myeloid leukemia and other cancers, serving patients with difficult-to-treat diseases and pharmaceutical development partners.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Space LiinTechand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →